BMJ appoints new chairman

Jay Lippincott has been appointed as BMJ’s non-executive chairman. He succeeds Michael Chamberlain, who is standing down after nearly 10 years as chairman, during which time the company is said to have more than doubled in size, and expanded globally. Lippincott has been a non-executive director of BMJ since January 2012, and consulted to the business, particularly on international opportunities, since 2009.

He is past president and CEO of the Professional & Education Unit of Wolters Kluwer’s Health Division. Prior to that, he was president and CEO of Kluwer Academic Publishers, now part of Springer Science + Business Media. He was also president of Lippincott Williams & Wilkins, Lippincott-Raven Publishers and Raven Press and before that held several executive leadership positions at J.B. Lippincott Company.

Michael Chamberlain commented: ‘I can think of no one more qualified to take over the chair at BMJ. He will be a great asset and I know that he will help BMJ achieve even higher levels of success.’